In patients with UTUC (Table 3), low expression of ZSCAN4 predicted worse DSS (P < 0.0001) (Fig. 4A) and MeFS (P < 0.0001) (Fig. 4B). This evidence concerns the gene ZSCAN4 and renal pelvis/ureter urothelial carcinoma.